Cargando…
Co-treatment of lower urinary tract symptoms and cardiovascular disease – where do we stand?
INTRODUCTION: The relationship between cardiovascular disease (CVD) and lower urinary tract symptoms (LUTS) is well established. A healthy lifestyle with a good quality diet and regular physical activity is important for reducing the severity of LUTS. MATERIAL AND METHODS: A literature search was pe...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Polish Urological Association
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7203768/ https://www.ncbi.nlm.nih.gov/pubmed/32395322 http://dx.doi.org/10.5173/ceju.2020.0029 |
_version_ | 1783529930241343488 |
---|---|
author | Semczuk-Kaczmarek, Karolina Płatek, Anna E. Szymański, Filip M. |
author_facet | Semczuk-Kaczmarek, Karolina Płatek, Anna E. Szymański, Filip M. |
author_sort | Semczuk-Kaczmarek, Karolina |
collection | PubMed |
description | INTRODUCTION: The relationship between cardiovascular disease (CVD) and lower urinary tract symptoms (LUTS) is well established. A healthy lifestyle with a good quality diet and regular physical activity is important for reducing the severity of LUTS. MATERIAL AND METHODS: A literature search was performed on the subject of association between LUTS and cardiovascular risk. RESULTS: The recent data indicates that therapy for cardiovascular risk reduction might also reduce the severity of LUTS (e.g. statins reduce the risk of benign prostatic hyperplasia [BPH] and slow down the progression of LUTS in patients with hyperlipidaemia). Hypertensive patients treated with angiotensin II receptor blockers have a lower severity of LUTS. This paper shortly discusses the relationship between the occurrence of LUTS and CVD and the potential clinical implications regarding the management of the patients. CONCLUSIONS: Patients with lower urinary tract symptoms require a holistic approach and cooperation of a urologist and cardiologist to diagnose concomitant cardiovascular diseases as early as possible and implement appropriate treatment. Antihypertensive, antithrombotic, hypolipemic therapies and healthy lifestyles reduce not only cardiovascular mortality, but also might reduce the severity of LUTS. |
format | Online Article Text |
id | pubmed-7203768 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Polish Urological Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-72037682020-05-11 Co-treatment of lower urinary tract symptoms and cardiovascular disease – where do we stand? Semczuk-Kaczmarek, Karolina Płatek, Anna E. Szymański, Filip M. Cent European J Urol Review Paper INTRODUCTION: The relationship between cardiovascular disease (CVD) and lower urinary tract symptoms (LUTS) is well established. A healthy lifestyle with a good quality diet and regular physical activity is important for reducing the severity of LUTS. MATERIAL AND METHODS: A literature search was performed on the subject of association between LUTS and cardiovascular risk. RESULTS: The recent data indicates that therapy for cardiovascular risk reduction might also reduce the severity of LUTS (e.g. statins reduce the risk of benign prostatic hyperplasia [BPH] and slow down the progression of LUTS in patients with hyperlipidaemia). Hypertensive patients treated with angiotensin II receptor blockers have a lower severity of LUTS. This paper shortly discusses the relationship between the occurrence of LUTS and CVD and the potential clinical implications regarding the management of the patients. CONCLUSIONS: Patients with lower urinary tract symptoms require a holistic approach and cooperation of a urologist and cardiologist to diagnose concomitant cardiovascular diseases as early as possible and implement appropriate treatment. Antihypertensive, antithrombotic, hypolipemic therapies and healthy lifestyles reduce not only cardiovascular mortality, but also might reduce the severity of LUTS. Polish Urological Association 2020-03-23 2020 /pmc/articles/PMC7203768/ /pubmed/32395322 http://dx.doi.org/10.5173/ceju.2020.0029 Text en Copyright by Polish Urological Association http://creativecommons.org/licenses/by-nc-sa/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license. |
spellingShingle | Review Paper Semczuk-Kaczmarek, Karolina Płatek, Anna E. Szymański, Filip M. Co-treatment of lower urinary tract symptoms and cardiovascular disease – where do we stand? |
title | Co-treatment of lower urinary tract symptoms and cardiovascular disease – where do we stand? |
title_full | Co-treatment of lower urinary tract symptoms and cardiovascular disease – where do we stand? |
title_fullStr | Co-treatment of lower urinary tract symptoms and cardiovascular disease – where do we stand? |
title_full_unstemmed | Co-treatment of lower urinary tract symptoms and cardiovascular disease – where do we stand? |
title_short | Co-treatment of lower urinary tract symptoms and cardiovascular disease – where do we stand? |
title_sort | co-treatment of lower urinary tract symptoms and cardiovascular disease – where do we stand? |
topic | Review Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7203768/ https://www.ncbi.nlm.nih.gov/pubmed/32395322 http://dx.doi.org/10.5173/ceju.2020.0029 |
work_keys_str_mv | AT semczukkaczmarekkarolina cotreatmentoflowerurinarytractsymptomsandcardiovasculardiseasewheredowestand AT płatekannae cotreatmentoflowerurinarytractsymptomsandcardiovasculardiseasewheredowestand AT szymanskifilipm cotreatmentoflowerurinarytractsymptomsandcardiovasculardiseasewheredowestand |